Is a complete AIM/TRLS research report available?

No complete published report is available for aim/TRLS (AIM/TRLS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/TRLS (AIM/TRLS)

London Stock Exchange AIM: AIM/TRLS · GBX

GBX 0.12

+0.00 (0.0%)· Recorded snapshot

Market cap	172K
Revenue (ttm)	262K
Net income (ttm)	-5M
EPS (ttm)	-GBX 0.03
Shares out	430.1M
Volume	2,801,829
Beta	2.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 262K
Net income (ttm): -5M
EPS (ttm): -GBX 0.03
Market cap: 172K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-14 02:00 UTC

All AIM/TRLS indicators

Market & fundamental data

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	18
Employees Change	-1%
Employees Change Percent	-5.26
Enterprise value	GBX -972,433
Exchange	London Stock Exchange AIM
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Healthcare Information Services
Isin	GB00BNNFM402
Last refreshed	2026-09-14
Market cap	GBX 172,048
Price	GBX 0.12
Price currency	GBX
Rev Per Employee	14,557.44x
Sector	Healthcare
Sector PE	20.55
Sector PE Fwd	13.32
Sic	8090
Symbol	aim/TRLS
Website	https://www.trellushealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2,922.18%
FCF yield	-2,646.19%
P/B ratio	0.03x
P/S ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	GBX 262,034
Gross Profit Growth	552.73%
Gross Profit Growth Q	490%
Gross Profit Growth3 Y	117.27%
Net Income	GBX -5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-1,918.66%
Profit Per Employee	GBX -279,308
ROA	-34.37
ROCE	-80.27
ROE	-56.65
ROIC	-35.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-82.88%
Cagr3y	-72.46%
Cagr5y	-71.15%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	552.73x
Revenue Growth Q	490x
Revenue Growth Qo Q	360.94x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	117.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.03
Assets	GBX 6.7M
Cash	GBX 1.1M
Current Assets	GBX 1.4M
Current Liabilities	GBX 379,270
Debt	GBX 0
Equity	GBX 6.4M
Liabilities	GBX 374,439
Long Term Assets	GBX 5.4M
Long Term Liabilities	GBX -4,831
Net Cash	GBX 1.1M
Net Cash By Market Cap	GBX 665
Net Cash Growth	-80.51%
Net Debt Equity	GBX -0.18
Tangible Book Value	GBX 989,015
Tangible Book Value Per Share	GBX 0.01
WACC	18.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.63
Net Working Capital	GBX -159,848
Quick ratio	3.63
Working Capital	GBX 984,635
Working Capital Turnover	GBX 0.06

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-82.86%
200-day SMA	0.55
3Y total return	-97.91%
50-day SMA	0.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.8%
All Time High	78
All Time High Change	-99.85%
All Time High Date	2021-06-15
All Time Low	0.04
All Time Low Change	200%
All Time Low Date	2026-08-25
ATR	0.05
Beta	2.51
Beta1y	1.19
Beta2y	2.04
Ch YTD	-68
High	0.12
High52	2.34
High52 Date	2026-01-21
High52ch	-94.86%
Low	0.04
Low52	0.04
Low52 Date	2026-08-25
Low52ch	200%
Ma50ch	-56.52%
Price vs 200-day SMA	-78.35%
RSI	22.09
RSI Monthly	26.13
RSI Weekly	32.37
Sharpe ratio	0.04x
Sharpe Ratio3y	0.34x
Sortino ratio	0.13
Sortino Ratio3y	1.69
Tr YTD	-68
Tr1w	200%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	374,589,072%
Shares Insiders	2.3%
Shares Institutions	70.35%
Shares Out	430,119,153
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -4.6M
Adjusted OCF	-4,563,064.5
Average Volume	22,412,350.25x
Bv Per Share	0.04
Ch1w	200
Ch1y	-82.86
Ch3y	-97.91
Ch5y	-99.8
Ch6m	-77.14
Change	0%
Change From Open	0
Close	0.12
Days Gap	0
Depreciation Amortization	43,619.7
Dollar Volume	336,219.5
Earnings Date	2026-09-08
EBIT	GBX -5.1M
EBITDA	GBX -5.1M
EPS	GBX -0.03
F Score	2
FCF	GBX -4.6M
FCF EV Yield	468.18x
FCF Per Share	GBX -0.01
Fiscal Year End	December
Founded	2,020
Investing CF	-212,401
Is Primary Listing	1
Last Earnings Date	2025-12-09
Last Report Date	2025-06-30
Ma150	0.51
Ma150ch	-76.62%
Ma20	0.16
Ma20ch	-24.05%
Net CF	-4,720,263
Open	0.12
Position In Range	100
Ppne	4,435.9
Price Date	2026-08-25
Ptbv Ratio	0.17
Relative Volume	0.13x
Revenue	262,034x
SBC By Revenue	3.9x
Share Based Comp	10,219
Tr6m	-77.14%
Volume	2,801,829
Z Score	-3.88

AIM/TRLS (AIM/TRLS)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/TRLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/TRLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/TRLS

Frequently asked questions